Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen says FDA wants more data on Prolia as a bone loss treatment, delaying potential approval
Amgen says FDA wants more data on Prolia as a bone loss treatment, delaying potential approval
Amgen says FDA wants more data on Prolia as a bone loss treatment, delaying potential approval
Submitted by
admin
on October 19, 2009 - 9:19am
Source:
Yahoo/AP
News Tags:
Amgen
FDA
Prolia
osteoporosis
Headline:
Amgen says FDA wants more data on Prolia as a bone loss treatment, delaying potential approval
Do Not Allow Advertisers to Use My Personal information
